https://www.biopharmaboardroom.com/news/13/4479/mirum-completes-enrollment-in-phase-3-expand-study-of-livmarli-for-cholestatic-pruritus-in-rare-liver-diseases.html
Mirum Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI for Cholestatic Pruritus in Rare...
Mirum Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI for Cholestatic Pruritus in Rare Liver Diseases
in phasecholestatic pruritusmirumcompletesenrollment
https://www.has-sante.fr/jcms/p_3556731/en/livmarli-maralixibat-progressive-intrahepatic-cholestasis-pfic?portal=p_3058934&userLang=en
Haute Autorité de Santé - LIVMARLI (maralixibat) - Progressive intrahepatic cholestasis (PFIC)
Inclusion on list. Favourable opinion for reimbursement in the “treatment of progressive familial intrahepatic cholestasis (PFIC) in patients 3 months of age...
intrahepatic cholestasishautelivmarlimaralixibatprogressive